Order results by:
Issue | Title | |
Vol 16, No 1 (2023) | Non-invasive respiratory support in patients with severe community-acquired pneumonia | Abstract similar documents |
S. V. Korotchenko, D. I. Korabelnikov | ||
"... Acute respiratory failure (ARF) is the leading cause of death in hospitalized patients with severe ..." | ||
Vol 15, No 1 (2022) | A systematic review of real-world clinical practice data in COVID-19: non-interventional studies | Abstract similar documents |
S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov | ||
"... . A search strategy for the terms “COVID-19 AND real-life”, “COVID-19 AND real-data”, “COVID-19 AND real ..." | ||
Vol 7, No 2 (2014) | ECONOMIC ANALYSIS OF USE OF IMMUNOCORRECTIVE PREPARATIONS FOR PREVENTION OF OFTEN RESPIRATORY INFECTIONS AND THEIR COMPLICATIONS AT CHILDREN OF SCHOOL AGE | Abstract similar documents |
R. V. Maiorov, D. P. Derbenev | ||
"... of respiratory infections at children of younger school age was made. It was revealed that carrying out ..." | ||
Vol 14, No 3 (2021) | Pharmacoeconomic aspects of COVID-19 treatment | Abstract similar documents |
I. V. Rogova, E. A. Zhidkova, I. A. Popova, A. V. Zaborovskiy, K. G. Gurevich | ||
"... The article provides an overview of global trends in various treatment approaches for COVID-19 ..." | ||
Vol 17, No 2 (2024) | Clinical and economic assessment of using topical bacterial lysate Imudon® for the treatment and prevention of acute upper respiratory tract infections in children | Abstract similar documents |
A. R. Kasimova, A. S. Kolbin | ||
"... ® for the treatment and prevention of acute upper respiratory tract infections in the pediatric population ..." | ||
Vol 16, No 4 (2023) | Socio-economic burden of respiratory syncytial viral infection of the lower respiratory tract in children aged from birth to 5 years in the Russian Federation: modeling results | Abstract similar documents |
V. I. Ignatyeva, D. Yu. Ovsyannikov, A. E. Tsygankov, E. E. Yagnenkova, V. R. Amirova, M. M. Maryanyan, A. S. Mokrova | ||
"... Background. Respiratory syncytial virus (RSV) is a common virus causing lower respiratory tract ..." | ||
Vol 17, No 2 (2024) | Clinical and economic assessment of using IRS®19 for the treatment and prevention of acute respiratory infections in children | Abstract similar documents |
A. S. Kolbin, A. R. Kasimova | ||
"... lysate in the form of nasal spray (IRS®19) for the treatment and prevention of upper respiratory tract ..." | ||
Vol 13, No 2 (2020) | COVID-19 pandemic: protective role of vitamin D | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, G. Kh. Gabdulina | ||
"... Introduction. The COVID-19 pandemic revealed the vulnerability of the general population ..." | ||
Vol 16, No 1 (2023) | Efficiency of Levilimab in patients with moderate and severe COVID-19 | Abstract similar documents |
Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov | ||
"... of moderate and severe COVID-19 based on real world data (RWD). Material and methods. A single-center ..." | ||
Vol 15, No 4 (2022) | Dietary factors influencing the COVID-19 epidemic process | Abstract PDF (Eng) similar documents |
S. V. Ponomarenko | ||
"... Coronavirus and identify factors that correlate withthe reduction in the severity of the consequences of COVID ..." | ||
Vol 14, No 2 (2021) | Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA | Abstract similar documents |
E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev | ||
"... and methods. The empirical base of the study includes more than 700 thousand tweets on Ebola and COVID-19 ..." | ||
Vol 16, No 2 (2023) | Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy | Abstract similar documents |
M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina | ||
"... or their combinations vs standard therapy in patients with mild and moderate-severe COVID-19 in order to prevent ..." | ||
Vol 13, No 4 (2020) | Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm | Abstract similar documents |
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov | ||
"... )-6 drugs: tocilizumab, olokizumab, and levilimab in patients with severe COVID-19 and cytokine storm ..." | ||
Vol 16, No 2 (2023) | Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance | Abstract similar documents |
N. Yu. Nikolenko, D. A. Kudlay, S. E. Borisov, T. E. Sannikova, N. P. Doktorova | ||
"... in patients with respiratory tuberculosis with multidrug- and extensively drug-resistant (MDR and XDR ..." | ||
Vol 14, No 3 (2021) | COVID-19 pandemic prediction model based on machine learning in selected regions of the Russian Federation | Abstract similar documents |
D. V. Gavrilov, R. V. Abramov, А. V. Kirilkina, А. А. Ivshin, R. E. Novitskiy | ||
"... Background. Prediction of the new coronavirus infection (COVID-19) spread is important to take ..." | ||
Vol 14, No 1 (2021) | Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19 | Abstract similar documents |
O. V. Zhukova, A. L. Khokhlov | ||
"... Background. Severe forms of COVID-19 are associated with the development of a cytokine storm ..." | ||
Vol 16, No 1 (2023) | Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin | ||
"... with COVID-19 and other respiratory viral infections were described in detail. Conclusion. Bioflavonoids ..." | ||
Vol 14, No 2 (2021) | Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev | ||
"... and safe drug-based treatment for COVID-19. Another approach seems promising: to reprofile ..." | ||
Vol 15, No 2 (2022) | Clinical study of real-time polymerase chain reaction test kit for SARS-CoV-2 ribonucleic acids detection | Abstract similar documents |
M. Yu. Dmitryukova, A. A. Golod, M. E. Senina, A. E. Gushchin | ||
Vol 13, No 4 (2020) | Peptides contained in the composition of Laennec that contribute to the treatment of hyperferritinemia and iron overload disorders | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, V. A. Maksimov, A. G. Chuchalin, V. G. Zgoda, А. N. Gromov, O. V. Tikhonova | ||
Vol 14, No 4 (2021) | Development of the system of state financing of Compulsory Health Insurance | Abstract similar documents |
А. V. Larionov, S. V. Russkikh, S. V. Maslennikov | ||
Vol 15, No 3 (2022) | Economic burden of the novel coronavirus infection: a systematic review | Abstract similar documents |
V. M. Timiryanova, I. A. Lakman, N. Sh. Zagidullin, D. F. Gareeva | ||
"... Background. The sudden emergence and rapid spread of the novel coronavirus infection (COVID-19 ..." | ||
Vol 15, No 3 (2022) | Funding for coronavirus health worker payments | Abstract similar documents |
I. Yu. Bocharova, A. Yu. Rymanov | ||
"... Objective: to conduct an analysis of the channels, the volume of COVID payments to medical workers ..." | ||
Vol 11, No 3 (2018) | Use of medications in children hospitalized with community-acquired pneumonia | Abstract similar documents |
D. D. Siukaeva, I. A. Narkevich, V. N. Timchenko, O. D. Nemyatyh, N. A. Maslova | ||
"... with that, 45.70% of patients had concomitant diseases; among those, acute respiratory infections of the upper ..." | ||
Vol 8, No 4 (2015) | PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER | Abstract similar documents |
D. A. Zhukov | ||
"... vaccination in working adults without occupational exposures on respiratory diseases from an employer ..." | ||
Vol 14, No 4 (2021) | Prospects of using chondroprotectors for the treatment of pulmonary pathology | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin | ||
"... the prospects for their use to inhibit inflammation in the respiratory tracts, allergic processes and to enhance ..." | ||
Vol 14, No 4 (2021) | Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy | Abstract similar documents |
I. Yu. Torshin, О. А. Gromova, V. G. Zgoda, А. G. Chuchalin, V. А. Maksimov, О. V. Tikhonova | ||
"... important in the rehabilitation of patients who have recovered from COVID-19. ..." | ||
Vol 17, No 3 (2024) | Biologically active supplements overview: regulation, market trends, application, and health impact | Abstract similar documents |
A. M. Stepanova, A. N. Plutnitskiy, E. V. Gameeva | ||
"... . The public health crisis caused by the COVID-19 pandemic as well as concerns about vaccines in many parts ..." | ||
Vol 14, No 2 (2021) | Systematic computer analysis of published literature on nutritional support for vaccination | Abstract similar documents |
A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova | ||
"... COVID-19. Additional micronutrient supply contributes to an increase in the effectiveness and safety ..." | ||
Vol 16, No 2 (2023) | Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients | Abstract similar documents |
E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov | ||
"... пациентов в течение 1 года. Заключение. Применение современных эффективных неинвазивных форм ОА (в ..." | ||
Vol 11, No 3 (2018) | Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review | Abstract similar documents |
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin | ||
"... , nasopharyngitis, upper respiratory and urinary tract infections, and headaches. No cases of progressive multifocal ..." | ||
Vol 11, No 4 (2018) | Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis | Abstract similar documents |
I. A. Narkevich, O. D. Nemyatyh, D. D. Siukaeva, I. V. Pavlushkov, D. O. Ivanov, Ya. V. Panyutina | ||
"... .g., medications aimed to correct morphological and functional changes in the respiratory system. ..." | ||
Vol 15, No 4 (2022) | Possibilities of physical therapy and electrophysical modalities in the complex therapy of pneumonia | Abstract similar documents |
D. I. Korabelnikov, V. V. Grigoryev, О. V. Efimova | ||
"... an expectorant effect, strengthens the respiratory muscles, accelerates the resorption of the inflammatory focus ..." | ||
1 - 34 of 34 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)